Trends and disparities in chronic ischemic heart disease mortality among adult cancer patients: a nationwide CDC WONDER analysis (1999-2020) [0.03%]
美国癌症患者慢性缺血性心脏病死亡率的流行趋势及其不平等现象（1999～2020年）——基于CDC数据库的分析研究
Soban Ali Qasim,Iftikhar Khan,Syed Saad Ul Hassan et al.
Soban Ali Qasim et al.
Background: Chronic ischemic heart disease (IHD) is a leading cause of cardiovascular-related mortality worldwide, with a growing burden among cancer patients due to shared risk factors and treatment-related Cardiotoxicit...
Validation of a novel semi-automated ECG quantification tool, applied to a cardio-oncology : Semi-automated ECG Tool applied to cardio-oncology [0.03%]
一种新型半自动心电图量化工具在心脏肿瘤学中验证：半自动ECG工具应用于心脏肿瘤学
Samuel D Cohen,Maxime Robert-Halabi,Adrien Procureur et al.
Samuel D Cohen et al.
Background: Electrocardiogram (ECG) analysis is crucial to detect cardiotoxicity. Manual methods are time-consuming and limited by inter-reader variability, highlighting the need for precise, reproducible and rapid semi-a...
Racial differences in breast cancer-specific mortality and CVD-specific mortality after breast cancer in post-menopausal women [0.03%]
绝经后妇女患乳腺癌后的乳腺癌特异性和心血管疾病特异性死亡的种族差异
Kerryn W Reding,Alexi L Vasbinder,Richard K Cheng et al.
Kerryn W Reding et al.
Background: Racial disparities in all-cause mortality after breast cancer (BC) have been documented. While elevated risk of BC mortality experienced by Black women is clear, it is unclear the relative contribution of card...
Redefining cardiac risk in breast radiotherapy: a substructure-based dosimetric and biomarker correlation study [0.03%]
基于亚结构的剂量学和生物标志物相关性研究重新定义乳腺放射治疗的心脏风险
Rishi P Nair,Depanshu Aggarwal,Atul Gupta et al.
Rishi P Nair et al.
Introduction: This study aimed to evaluate the efficacy of the mean heart dose (MHD) as a predictor of radiation exposure to cardiac substructures and its association with markers of subclinical cardiotoxicity in breast c...
Association between systemic inflammation and risk of atrial fibrillation in cancer survivors: a population-based cohort study using UK biobank [0.03%]
基于UK Biobank的队列研究：癌症幸存者系统性炎症与房颤风险之间的关联
Quan Yang,Jiazhen Zheng,Chunting Zhao et al.
Quan Yang et al.
Background: Cancer survivors (CSs) are at increased risk of atrial fibrillation (AF), potentially due to cancer-related inflammation and treatment effects. While inflammation has been implicated in both cancer and AF, the...
Prospective multicenter evaluation of 18F-FDG PET/CT and strain for early cardiotoxicity detection in lymphoma patients [0.03%]
前瞻性多中心研究评估18F-FDG PET/CT和应变在淋巴瘤患者早期心毒性的检测中的应用
Mônica de Moraes Chaves Becker,Roberto de Oliveira Buril,Mauro Rogério de Barros Wanderley Júnior et al.
Mônica de Moraes Chaves Becker et al.
Background: Anthracycline-induced cardiotoxicity (CTX) requires close monitoring in lymphoma patients. Increased myocardial uptake of fluorine-18-fluorodeoxyglucose (18F-FDG) via positron emission tomography combined with...
Bridging gaps in AI-driven cardio-oncology: global advances and Middle East perspectives [0.03%]
人工智能驱动的心脏肿瘤学中的缺口：全球进展和中东展望
Arif Albulushi,Hatem Al-Farhan
Arif Albulushi
Background: Cardiotoxicity remains a critical barrier to effective cancer treatment, contributing significantly to morbidity and mortality in cancer survivors. Recent advancements (2020-2025) highlight artificial intellig...
Clinical characteristics and treatment outcomes of primary cardiac sarcomas: a retrospective analysis [0.03%]
原发性心脏肉瘤的临床特征及治疗结局分析：一项回顾性研究
Jun Cao,Zhichao Tan,Enyu Yang et al.
Jun Cao et al.
Objectives: Primary cardiac sarcomas (PCSs) are uncommon malignant tumors with a poor prognosis. This study aims to present the clinical characteristics and treatment outcomes for PCS observed in our centers. ...
CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis [0.03%]
高危AML患者采用CPX-351与常规化疗的后设分析的III期临床试验的心脏毒性
Joshua D Mitchell,Michael Pfeiffer,John Boehmer et al.
Joshua D Mitchell et al.
Background: CPX-351, a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic 1:5 molar ratio, has demonstrated significantly improved overall survival in acute myeloid leukemia (AML) compared w...
Electrocardiographic manifestations and targeted management of cardiac complications in cardiac-involved DLBCL: a retrospective case series [0.03%]
心脏受累的DLBCL患者的心电图表现及心脏并发症的目标管理：病例系列回顾研究
Jen-Yu Chuang,Kuan-Ting Chen,Johnson Lin et al.
Jen-Yu Chuang et al.
Background: Cardiac involvement in diffuse large B-cell lymphoma (DLBCL) is rare but often complicated by life-threatening arrhythmias, conduction disturbances, and heart failure. Electrocardiography (ECG) is essential fo...